all report title image

BILIRUBIN COLORIMETER ASSAY MARKET ANALYSIS

Bilirubin Colorimeter Assay Market, by Bilirubin Type (Conjugated Bilirubin (Direct Bilirubin) and Unconjugated Bilirubin (Indirect Bilirubin)), by Disease Indication (Jaundice, Hemolytic Anemia, Hyperbilirubinemia, Hepatitis, Bilirubin Encephalopathy (Kernicterus), and Others), by End User (Hospitals, Diagnostic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI2292
  • Formats :
      Excel and PDF
  • Industry : Clinical Diagnostic

Bilirubin Colorimeter Assay MarketSize and Trends

Bilirubin Colorimeter Assay Market Drivers

Bilirubin assay kits are widely used for the diagnosis of liver dysfunction, jaundice, hemolytic Anemia, and metabolic disorders, including hepatitis and gall bladder block. According to the data published by Centers of Disease Control and Prevention in 2018, about 60% of all newborn babies in the U.S. suffer from jaundice, some babies are more likely to have severe jaundice and higher bilirubin levels than others. According to the same source, it was estimated that in 2016, around 4.9 million people in the U.S. were diagnosed with some kind of liver disease.

High incidences of jaundice and liver related diseases is expected to be a major driving force for bilirubin colorimeter assay market growth during the forecast period.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.